v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Segment Reporting (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Segment Reporting [Line Items]    
Revenue  
Operating expenses:    
Research and development 1,632,581
General and administrative 10,279,981 1,275,095
Total operating expenses 11,912,562 1,275,095
Loss from operations (11,912,562) (1,275,095)
Other income (expense), net:    
Realized gain on sale of digital assets 4,197,394
Trading gains, net 97
Unrealized gain on digital assets 1,812,348
Change in FV of derivative 55,146
Change in FV of warrant liability 22,377
Interest income 107,595 2,824
Interest expense (283,011) (117,719)
Foreign currency transaction loss (521)
Total other income (expense), net 5,911,425 (114,895)
Net loss (6,001,137) $ (1,389,990)
BioBusiness Segment [Member]    
Schedule of Segment Reporting [Line Items]    
Revenue  
Operating expenses:    
Research and development 1,632,581  
General and administrative 7,179,165  
Total operating expenses 8,811,746  
Loss from operations (8,811,746)  
Other income (expense), net:    
Realized gain on sale of digital assets  
Trading gains, net  
Unrealized gain on digital assets  
Change in FV of derivative  
Change in FV of warrant liability  
Interest income  
Interest expense  
Foreign currency transaction loss  
Total other income (expense), net  
Net loss (8,811,746)  
Digital Asset Segment [Member]    
Schedule of Segment Reporting [Line Items]    
Revenue  
Operating expenses:    
Research and development  
General and administrative 3,100,816  
Total operating expenses 3,100,816  
Loss from operations (3,100,816)  
Other income (expense), net:    
Realized gain on sale of digital assets 4,197,394  
Trading gains, net 97  
Unrealized gain on digital assets 1,812,348  
Foreign currency transaction loss (521)  
Total other income (expense), net 6,009,317  
Net loss 2,908,502  
Corporate Segment [Member]    
Schedule of Segment Reporting [Line Items]    
Revenue  
Operating expenses:    
Research and development  
General and administrative  
Total operating expenses  
Loss from operations  
Other income (expense), net:    
Realized gain on sale of digital assets  
Trading gains, net  
Unrealized gain on digital assets  
Change in FV of derivative 55,146  
Change in FV of warrant liability 22,377  
Interest income 107,595  
Interest expense (283,011)  
Foreign currency transaction loss  
Total other income (expense), net (97,867)  
Net loss $ (97,867)